Evidence Still Weak For Cancer Prevention By Nutrition
Preamble: I am including this article because I believe it is important for readers to make their own judgement on reports of this nature. I would however, urge readers to exercise caution with any research that does not give details of sponsorship and funding of that research.
Visit us online at MedPageToday.com
Evidence Still Weak For Cancer Prevention By Nutrition
By Michael Smith, MedPage Today Staff Writer
Reviewed by Zalman S. Agus, MD; Emeritus Professor at the University of Pennsylvania School of Medicine.
July 19, 2006
Source News Article: Forbes, Fox News
MedPage Today Action Points
* Advise patients who ask that this study suggests that evidence in the scientific literature is lacking to support the hypothesis that dietary modification by cancer patients improves survival and benefits disease prognosis.
* Continue to suggest that all patients follow a recommended healthy diet because many patients with cancer and preinvasive lesions will live a long time and may die of other diseases related to diet.
Review
BETHESDA, Md., July 19 — Dietary supplements such as antioxidants, vitamins, and garlic do little if anything to prevent cancer, but antibiotics aimed at cancer-causing bacteria appear to prevent some tumors.
Those are the conclusions of two studies reported in the July 19 issue of the Journal of National Cancer Institute - one a large, long-term randomized trial in pre-cancerous gastric lesions and the other a meta-analysis of studies in a range of cancer types and pre-cancerous lesions.
Researchers here and in China conducted a randomized, placebo-controlled, factorial study, comparing three possible chemopreventive treatments for gastric lesions in a region known for a high incidence of gastric cancer, according to Mitchell Gail, M.D., Ph.D., of the National Cancer Institute here.
The study, carried out in the Chinese province of Shandong, began in 1994, when the researchers enrolled 3,365 participants, ages 35 to 64, and randomly assigned them, in a factorial fashion to three interventions or placebos:
* Amoxicillin and omeprazole for two weeks in 1995, to treat Helicobacter pylori infection
* A vitamin supplement consisting of vitamin C, vitamin E, and selenium, for 7.3 years
* Or a garlic supplement, consisting of an aged garlic extract and steam-distilled garlic oil, for 7.3 years.
The participants underwent a baseline endoscopy, with follow-up procedures in 1999 and 2003. At baseline, they included all histologic categories except gastric cancer, although only 0.18% had normal gastric mucosa.
The study found that H. pylori treatment resulted in statistically significant decreases in the combined prevalence of severe chronic atrophic gastritis, intestinal metaplasia, dysplasia, or gastric cancer in 1999 and again in 2003. The odds ratios were 0.77 in 1999, with a 95% confidence interval from 0.62 to 0.95, and 0.60 in 2004, with a 95% confidence interval from 0.47 to 0.75.
The treatment didn’t reduce the combined prevalence of dysplasia or gastric cancer, although 19 of the 1,130 participants getting antibiotics (1.7%) developed gastric cancer compared to 27 of 1,128 getting placebo (or 2.4%). The trend was not significant, however.
On the other hand, no significant favorable effects were seen for garlic or vitamin supplements, the researchers reported.
The randomized trial had outcomes similar to that seen in a meta-analysis of 59 studies, in that the vitamin supplements and antioxidants did not appear to have a consistent beneficial effect.
Researchers led by Steven Thomas, M.D., Ph.D., of the University of Bristol, in England, identified 25 studies in patients with cancer and 34 in patients with pre-invasive lesions, but overall there was no association between either the antioxidants or vitamin A supplements and all-cause mortality.
On the other hand, Dr. Thomas and colleagues found a trend toward benefit for a “healthy diet.” The combined odds ratio for such a diet — alone or with dietary supplements, weight loss, or exercise - on all-cause mortality was 0.90. However, the 95% confidence interval crossed unity, so the association was not statistically significant.
The quality of the studies analyzed was low, the researchers said, which combined with the limited number of such studies, makes it hard to estimate the effects of nutritional interventions. Nevertheless, “there is no evidence that dietary modification by cancer patients improves survival and benefits disease prognosis,” the researchers concluded.
The two studies “well illustrate the contemporary status of chemoprevention,” said John Baron, M.D., of Dartmouth Medical School, in Lebanon, N.H.., in an accompanying editorial. Chemoprevention is “hard to summarize, (with) many negative findings, but some hopeful nuggets of progress,” Dr. Baron summed up.
He noted that Dr. Thomas and colleagues used a relatively narrow definition of quality, focusing on randomization and blinding, but “most of the negative assessments actually reflected a lack of reporting, so arguably a better characterization of the trial quality might be ‘unknown.’”
Primary source: Journal of the National Cancer Institute
Source reference:
Anna A. Davies et al. “Nutritional Interventions and Outcome in Patients With Cancer or Preinvasive Lesions: Systematic Review.” J Natl Cancer Inst 2006;98)14): 961-973.
Additional source: Journal of the National Cancer Institute
Source reference:
Wei-cheng You et al. :Randomized Double-Blind Factorial Trial of Three Treatments to Reduce the Prevalence of Precancerous Gastric Lesions.” J Natl Cancer Inst 2006; 98:974-983.
Additional source: Journal of the National Cancer Institute
Source reference:
John A. Baron. “(Nutritional) Chemoprevention of Cancer: What’s Up?” J Natl Cancer Inst 2006; 98:945-946.
Disclaimer
The information presented in this activity is that of the authors and does not necessarily represent the views of the University of Pennsylvania School of Medicine, MedPage Today, and the commercial supporter. Specific medicines discussed in this activity may not yet be approved by the FDA for the use as indicated by the writer or reviewer. Before prescribing any medication, we advise you to review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects. Specific patient care decisions are the responsibility of the healthcare professional caring for the patient. Please review our Terms of Use.
© 2004-2006 MedPage Today, LLC. All Rights Reserved.
Copyright ©2006